Mange af disse patienter led i forvejen af diffuse symptomer, hvoraf nogle var behandlingskrævende med præparater, der har været associeret med udviklingen af diabetes mellitus eller hyperglykæmi.
Many patients had confounding medical conditions, some of which required therapy with agents that have been associated with the development of diabetes mellitus or hyperglycaemia.